Laguna Diagnostics secures FDA breakthrough tag for mRNA test in psychiatric diagnosis
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder
The move puts a spotlight on one of psychiatry’s most persistent clinical challenges: misdiagnosis and delay
Subscribe To Our Newsletter & Stay Updated